I would also like to turn your attention to intellectual property (IP). I thought that was really important, as well, that we address that intellectual property should be seen as a normal property right. Just because a firm has IP over a particular idea or particular technology, that doesn't automatically give them market right. We see that with a lot of the drug buyers, the pharmaceutical companies, when we see IP and they have IP and it gives them an unfair advantage in the market. We see that creates a lot of problems. This bill and this change, of removing intellectual property as being a safe haven from being prosecuted for anti-competitive behaviour, gives our market a really good chance—like Jamie Strange has just mentioned—to bring about more competition so that we have better incentives to encourage our firms to innovate. I think that's really important because, in New Zealand, as a small country, not only do we start on the back leg in terms of our size, our quantity in our economy, we have to be smart about the way that we place ourselves in the global market, as well as setting up our domestic market. So fresh, new ideas that really would be high value are really important, and innovation, I really think, is the key road in terms of achieving greater economic success for our country, and achieving greater welfare for all of us who live in Aotearoa New Zealand.